PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
05-Mar-2020 Alligator Bioscience Appoints Andreas Johannesson as interim Chief Financial Officer Alligator Bioscience
05-Mar-2020 AbbVie Inc. - Form 8.1 - Statement of Stock Purchase by Director AbbVie
04-Mar-2020 FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast U.S. Food and Drug Administration
04-Mar-2020 Notice of Preliminary Results Ergomed plc
04-Mar-2020 Interim Results for the six months ended 31 December 2019 Allergy Therapeutics plc
04-Mar-2020 Abcam extends assay and labelling capabilities with the acquisition of Marker Gene Technologies Abcam
04-Mar-2020 New disinfection spray from Lipidor and Aurena Laboratories Lipidor AB
04-Mar-2020 HRA Pharma expands into South Africa with Compeed(R) HRA Pharma
04-Mar-2020 TISSIUM Awarded 2.2M€ from i-Nov Competition to Address Chronic Rhinosinusitis TISSIUM
04-Mar-2020 Call for Applications: 2021 Vilcek Prizes for Creative Promise in Biomedical Science The Vilcek Foundation
04-Mar-2020 Sirnaomics to Present at 5th Annual Oligonucleotide & Precision Therapeutics Congress Sirnaomics, Inc.
04-Mar-2020 NMI® at 57.3%; GDP Growing at 3%; February 2020 Non-Manufacturing ISM® Report On Business® Institute for Supply Management
04-Mar-2020 Cinclus Pharma Raises SEK 250 Million for the Continued Development of a Novel Treatment Against Gastroesophageal Reflux Disease Cinclus Pharma
03-Mar-2020 DURECT Corporation Announces Fourth Quarter and Full Year 2019 Financial Results and Update of Programs DURECT Corporation
03-Mar-2020 Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals, Inc.
03-Mar-2020 Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results Kindred Biosciences, Inc.
03-Mar-2020 FDA Informs Patients, Providers and Manufacturers About Potential Cybersecurity Vulnerabilities in Certain Medical Devices with Bluetooth Low Energy U.S. Food and Drug Administration
03-Mar-2020 Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs Chi-Med
03-Mar-2020 Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress Autolus Therapeutics plc
03-Mar-2020 Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizumab for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited